.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Management of Dry Eye Disease

Dr Laura Periman, MD discusses biopsychosocial and economic impacts, as well as innovative treatment opportunities for patients with dry eye disease.

EP. 1: Pathology and Prevalence of Dry Eye Disease

June 7th 2022

Dr Laura Periman, MD illustrates the current risk factors and prevalence regarding patients with dry eye disease.

EP. 2: Impact of Dry Eye Disease on Quality of Life

June 14th 2022

Quality-of-life concerns, including biopsychosocial impacts caused by dry eye disease, are explored by Dr Periman.

EP. 3: Identifying Drivers of Economic Burden Associated With Dry Eye Disease

June 21st 2022

Dr Periman addresses cost-related concerns associated with treating dry eye disease.

EP. 4: Exploring Non-Pharmacologic Treatment Options for Patients With Dry Eye Disease

June 28th 2022

Various treatments for dry eye disease are navigated with regard to both payer and provider considerations.